EUVIMEDEUVIMED entdecken
Open Access

Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice

Jesse A Columbo iD, David H Stone, Pablo Martinez-Camblor iD, Philip P Goodney iD, A James O'Malley iD

Circulation: Cardiovascular Interventions · 2023-09 · 16 (9)

DOI: 10.1161/circinterventions.122.012805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Interventions, 2023-09. Verfasst von Jesse A Columbo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Section of Vascular Surgery, Heart and Vascular Center (J.A.C., D.H.S., P.P.G.), Dartmouth-Hitchcock Medical Center, Lebanon, NH. Hauptthemen laut MEDLINE: Carotid Stenosis, Stroke. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: In 2015, the FDA approved transcarotid artery revascularization (TCAR) as an alternative to carotid endarterectomy (CEA) and transfemoral carotid artery stenting (TF-CAS) for high-risk patients with carotid stenosis. This was granted in the absence of level 1 evidence to support TCAR. We aimed to document trends in TCAR utilization, its diffusion over time, and the clinical phenotypes of patients undergoing TCAR, CEA, and TF-CAS. METHODS: We used the Vascular Quality Initiative to study patients who underwent TCAR. We calculated the number of TCARs performed and the percent of TCAR utilization versus CEA/TF-CAS. Using data from before TCAR was widespread, we calculated propensity scores for patients to receive CEA. We applied this model to patients undergoing carotid revascularization from 2016 to 2022 and grouped patients by the procedure they ultimately underwent, examining overlap in score distribution to measure patient similarity. We measured the trend of in-hospital stroke/death after TCAR. RESULTS: We studied 31 447 patients who underwent TCAR from January 1, 2016 to March 31, 2022. The number of centers performing TCAR increased from 29 to 606. In 2021, TCAR represented 22.5% of carotid revascularizations at centers offering all 3 procedures. The percentage of patients that underwent TCAR who met approved high-risk criteria decreased from 88.5% to 80.9% ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carotid StenosisStrokeHumansStentsTreatment OutcomeArteries

Stichwörter der Autor:innen

endarterectomyphenotypepropensity scorerisk factorstent

Autor:innen und Institutionen

  • Section of Vascular Surgery, Heart and Vascular Center (J.A.C., D.H.S., P.P.G.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
  • Geisel School of Medicine at Dartmouth College, Hanover, NH (J.A.C., D.H.S., P.P.G., A.J.O.).
  • Department of Anesthesia (P.M.-C.), Dartmouth-Hitchcock Medical Center, Lebanon, NH.
  • Department of Biomedical Data Science, Dartmouth College, Hanover, NH (P.M.-C., A.J.O.).

ORCID-Profile: Jesse A Columbo, Pablo Martinez-Camblor, Philip P Goodney, A James O'Malley

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Columbo, J. A., Stone, D. H., Martinez-Camblor, P., Goodney, P. P., & O'Malley, A. J. (2023). Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice. Circulation: Cardiovascular Interventions, 16(9). https://doi.org/10.1161/circinterventions.122.012805

Vancouver

Columbo JA, Stone DH, Martinez-Camblor P, Goodney PP, O'Malley AJ. Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice. Circulation: Cardiovascular Interventions. 2023;16(9). doi:10.1161/circinterventions.122.012805

BibTeX
@article{Columbo2023,
  author = {Columbo, Jesse A and Stone, David H and Martinez-Camblor, Pablo and Goodney, Philip P and O'Malley, A James},
  title = {Adoption and Diffusion of Transcarotid Artery Revascularization in Contemporary Practice},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2023},
  volume = {16},
  number = {9},
  doi = {10.1161/circinterventions.122.012805}
}
Kostenlos starten →